Assignee
NANJING IMMUNOPHAGE BIOTECH CO LTD
CN·3 granted patents·7 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
10 records- 0169US2024083912A1Compounds and their uses as mif inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0261US2025382283A1Compounds and their uses as cd38 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 0359US2024254113A1Compounds and their uses as cd38 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0459US2026027095A1Compounds as Inhibitors of Macrophage Migration Inhibitory Factor and the Use ThereofNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0553US11884682B2Compounds and their uses as MIF inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Granted Jan 30, 2024·0 cites·14 claims
- 0652US2023038589A1Methods and compositions for targeting Tregs using CCR8 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 0752US2024352134A1Anti-CCR8 Antibodies and Uses ThereofNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0850US2025034121A1Compounds and their uses as gpr183 inhibitorsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0949US12441795B2Anti-ROR1 antibodies and preparation method and uses thereofNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·20 claims
- 1044US12497453B2ROR1 specific chimeric antigen receptors and their therapeutic applicationsNANJING IMMUNOPHAGE BIOTECH CO LTD·Filed 2020·Granted Dec 16, 2025·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when NANJING IMMUNOPHAGE BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →